While the JNK/pSmad3L/c-Myc pathway is associated with tumor growth during HCC, the signaling depending on IL-37 diverts pSmad3L from that platform and associates it with the suppressor of tumor p21 in a pSmad3C/p21 complex. Here, IL37 is linked to neoplasm.